(Senior) Brand Manager Neurology at Eli Lilly and Company

Utrecht, Utrecht, Netherlands

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor- and/or master's degree
Experience with and a network in neurology is a plus
Strong affinity with the therapeutic area of Alzheimer
Experience in a similar role in a pharmaceutical company is required

Responsibilities

Conducting market analyses and documenting market requirements for positioning Kisunla on the Dutch market
Anticipating trends in the healthcare environment and determining new directions if necessary
Integrating new channels into a holistic marketing mix
Maintaining an excellent external focus on customer groups (thought leaders), in this case neurologists and geriatricians, to understand customer needs and business opportunities
Being able to support an advanced key account management strategy
Setting priorities
Managing budget and supply chain
Collaborating closely with other Brand Managers within the organization to share marketing programs and solutions to problems
Keeping senior management and other key stakeholders informed about progress in realizing the product strategy
Ensuring compliance with new and existing programs
Being responsible for managing the customer dialogue process (Customer Dialogue Management - CDM)
Managing suppliers and agencies and utilizing procurement processes

Skills

Brand Management

Marketing Strategy

Pharmaceutical Marketing

Neurology

Alzheimer's Disease

Market Launch

Customer Plan Development

Strategic Planning

Stakeholder Engagement

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free